selected publications
-
The R136S mutation in the APOE3 gene confers resilience against tau pathology via inhibition of the cGAS-STING-IFN pathway.
Immunity.
2025
Academic Article
GET IT
Times cited: 3 -
Virtual care in community pharmacy services: a scoping review.
Research in social & administrative pharmacy : RSAP.
2025
Academic Article
GET IT
Times cited: 1 - APOE3-R136S mutation confers resilience against tau pathology via cGAS-STING-IFN inhibition. 2025 GET IT
- Cellular and pathological functions of tau. Nature reviews. Molecular cell biology. 2024 Review GET IT
-
NRF2/ARE mediated antioxidant response to glaucoma: role of glia and retinal ganglion cells.
Acta neuropathologica communications.
2023
Academic Article
GET IT
Times cited: 6 -
Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE Pathway.
Antioxidants (Basel, Switzerland).
2023
Academic Article
GET IT
Times cited: 6 -
Retinal oxidative stress activates the NRF2/ARE pathway: An early endogenous protective response to ocular hypertension.
Redox biology.
2021
Academic Article
GET IT
Times cited: 43 -
Intravitreal injection worsens outcomes in a mouse model of indirect traumatic optic neuropathy from closed globe injury.
Experimental eye research.
2020
Review
GET IT
Times cited: 12 -
Microsphere antioxidant and sustained erythropoietin-R76E release functions cooperate to reduce traumatic optic neuropathy.
Journal of controlled release : official journal of the Controlled Release Society.
2020
Academic Article
GET IT
Times cited: 17 -
Galantamine protects against synaptic, axonal, and vision deficits in experimental neurotrauma.
Neurobiology of disease.
2019
Academic Article
GET IT
Times cited: 20 -
Progression and Pathology of Traumatic Optic Neuropathy From Repeated Primary Blast Exposure.
Frontiers in neuroscience.
2019
Academic Article
GET IT
Times cited: 29